【教育经历】
1.2000.9至2005.7，南方医科大学临床医学系，临床医学，学士
2.2005.9至2010.7，华中科技大学同济医学院神经内科，神经病学，博士
3.2010.9至2013.7，首都医科大学附属北京天坛医院，神经病学，博士后
【工作经历】
2013年7月至今，首都医科大学附属北京天坛医院、国家神经系统疾病临床医学研究中心
【主要讲授课程】
1.
【科研项目】
1.基于多组学的缺血性脑血管病发生发展机制研究--缺血性脑血管病新靶点功能验证及临床前评价研究（课题三），2022-2025年，300万，主持。
2.BMP6通过调节脂肪酸代谢调控内皮间质转化在动脉粥样硬化中的作用及机制研究，2024-2027年，14.0万，主持。
3.急性缺血性卒中患者静脉溶栓人工智能系统的开发剂验证，2020-2023年，47万，主持。
4.肠道菌群及其产物在卒中急性期血压调控中的作用机制研究，2018.01-202年, 20万，主持。
【主要论著】
1. Cheng A, Jie Xu, Wang A, Xu Q, Feng Z, Lin J, Li H, Meng X, Xu J, Wang Y. LDL-C Levels and Bleeding Risk in Patients Taking DAPT After Minor Ischemic Stroke or TIA. JAMA Neurol. 2024 Mar 4;81(4):354–62.(一区；IF=20.4)
2. Jie Xu#, Xing Zhang#, Aoming Jin#， Yuesong Pan, Zixiao Li, Xia Meng, Yongjun Wang. Trends and Risk Factors Associated With Stroke Recurrence in China, 2007-2018. JAMA Netw Open. 2022;5(6):e2216341. (一区；IF=13.353)
3. Jie Xu#, Anxin Wang#, Runqi Wangqin#, Jinglin Mo, Zimo Chen, Liye Dai, Xia Meng, Xingquan Zhao, Yilong Wang, Hao Li, Wei Chen, Ying Xian, Yongjun Wang* Efficacy of Clopidogrel for Stroke Depends on CYP2C19 Genotype and Risk Profile. Ann Neurol. 2019,86(3):419-426(一区；IF=11.274)
4. Tao Zhang#, Jie Xu#, Shengxu Li, Lydia A Bazzano, Jiang He, Paul K Whelton, Wei Chen* Trajectories of childhood BMI and adult diabetes: the Bogalusa Heart Study. Diabetologia. 2019,62(1):70-77 (一区；IF=10.460)
5. Jie Xu #, Xiwa Hao #,Rui Zhan #, Xue Jiang, Aoming Jin, Jing Xue,Aichun Cheng, Jiewen Liu, Jinxi Lin, Xia Meng, Hao Li, Lemin Zheng*, Yongjun Wang*. The Effect of Lipoprotein(a) on Stroke Recurrence Attenuates at Low LDL-C and Inflammation Levels. stroke. 2022 Aug;53(8):2504-2511. (一区；IF=10.170)
6. Jie Xu # , Aichun Cheng #, Bo Song #, Mingming Zhao, Jing Xue, Anxin Wang, Liye Dai,Jing Jing, Xia Meng , Hao Li, Lemin Zheng*, Yongjun Wang*. Trimethylamine N-Oxide and Stroke Recurrence Depends on Ischemic Stroke Subtypes. stroke. 2022 Apr;53(4):1207-1215. (一区；IF=10.170)
7. Jie Xu#, Liye Dai#, Yijun Zhang, Anxin Wang, Hao Li, Yilong Wang, Xia Meng, Shouling Wu, Yongjun Wang*. Severity of Nonalcoholic Fatty Liver Disease and Risk of Future Ischemic Stroke Events. stroke. 2021,52(1):103-110. (一区；IF=10.170)
8. Jie Xu#, Anxin Wang#, Xia Meng #, Gulbahram Yalkun, Anding Xu, Zhiqiang Gao, Huisheng Chen, Yong Ji, Jun Xu, Deqin Geng, Runxiu Zhu, Bo Liu, Aiqin Dong, Hua Mu, Zhihong Lu, Shuya Li, Huaguang Zheng, Xia Chen, Yilong Wang, Xingquan Zhao, Yongjun Wang*. Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke: A Phase III, Randomized, Double-Blind, Comparative Trial. stroke. 2021,52(3):772-780 (一区；IF=10.170）
9. Jie Xu#, Gulbahram Yalkun#, Meng Wang, Anxin Wang, Runqi Wangqin, Xiaoli Zhang, Zimo Chen, Jinglin Mo, Xia Meng, Hao Li, Zixiao Li, Yongjun Wang*. Impact of infection on the risk of recurrent stroke among patients with acute ischemic stroke. stroke. 2020;51(8):2395-2403 (一区；IF=10.170）
10. Jinglin Mo#, Zimo Chen#, Jie Xu#, Anxin Wang, Liye Dai, Aichun Cheng, Xia Meng, Hao Li, Yongjun Wang*. Efficacy of clopidogrel-aspirin therapy for stroke does not exist in cyp2c19 loss-of-function allele noncarriers with overweight/obesity. stroke. 2020,51(1):224-23.(一区；IF=10.170）
11. Jie Xu#, Anxin Wang#, Xia Meng, Jing Jing, Yilong Wang, Yongjun Wang*. Obesity-stroke paradox exists in insulin-resistant patients but not insulin sensitive patients. stroke. 2019,5(2):STROKEAHA118023817 (一区；IF=10.170)
【学术兼职】
中国卒中学会脑血管病高危人群管理分会——常委
